| 11 Jun, 01:54 pm | regulatory_action | 1 | Cipla Ltd - 500087 - USFDA Inspection At Company'S Manufacturing Facility In Verna, Goa, India | bse |
| 09 Jun, 07:36 pm | procedural | 0 | Cipla Limited filed a corrigendum to its earlier June 1, 2026 intimation regarding the Notice of the 90th AGM and the Integrated Annual Report for FY 2025-26. | nse |
| 08 Jun, 10:06 pm | — | … | Cipla Limited has informed the Exchange about communication on tax deduction at source on final dividend for FY 2025-26. | nse |
| 01 Jun, 11:37 pm | — | … | Cipla Limited has informed the Exchange regarding BRSR for FY2025-26 | nse |
| 01 Jun, 11:28 pm | — | … | Cipla Ltd - 500087 - Reg. 34 (1) Annual Report. | bse |
| 29 May, 08:48 pm | — | … | Cipla Ltd - 500087 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 21 May, 05:03 pm | — | … | Cipla Limited has informed the Exchange about Newspaper advertisement titled "Notice of the 90th AGM to be held through Video Conferencing, Record Date and Final Dividend" | nse |
| 15 May, 06:33 pm | — | … | Cipla Limited has informed the Exchange about Transcript | nse |
| 15 May, 06:25 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 14 May, 12:11 pm | — | … | Cipla Limited has informed the Exchange regarding allotment of 17915 securities pursuant to ESOP/ESPS on May 14, 2026 | nse |
| 13 May, 08:01 pm | — | … | Cipla Limited has informed the Exchange about Link of Recording | nse |
| 13 May, 07:50 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 13 May, 01:22 pm | — | … | Cipla Limited has informed the Exchange regarding grant of stock options and the employee stock appreciation rights . | nse |
| 13 May, 01:17 pm | — | … | Cipla Limited has informed the Exchange regarding Appointment of Ms Joshi Apte & Associates as Cost Auditors of the company w.e.f. April 01, 2026. | nse |
| 13 May, 01:14 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 13 May, 01:13 pm | — | … | Cipla Limited has informed the Exchange regarding Appointment of Mr Sushrut Kulkarni as President & Global Chief Integrated Product Development of the company w.e.f. May 18, 2026. | nse |
| 13 May, 01:09 pm | — | … | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2026. | nse |
| 13 May, 01:03 pm | — | … | Cipla Limited has informed the Exchange about Investor Presentation | nse |
| 13 May, 01:00 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 13 May, 12:59 pm | — | … | Cipla Limited has informed the Exchange regarding a press release dated May 13, 2026. | nse |
| 13 May, 12:56 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 13 May, 12:48 pm | — | … | Cipla Ltd - 500087 - Record Date For Payment Of Final Dividend For FY 2025-26 | bse |
| 13 May, 12:45 pm | — | … | Cipla Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Jun-2026. | nse |
| 13 May, 12:43 pm | — | … | Cipla Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2026, recommended Final Dividend of Rs. 13 per equity share. | nse |
| 13 May, 12:40 pm | — | … | Cipla Ltd - 500087 - Corporate Action-Board approves Dividend | bse |
| 13 May, 12:36 pm | — | … | Cipla Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 13 May, 12:35 pm | — | … | Cipla Ltd - 500087 - Audited Financial Results And Recommendation Of Final Dividend | bse |
| 23 Apr, 09:48 am | — | … | Cipla receives U.S. FDA approval for first AB Rated Generic of Ventolin® HFA | nse |
| 17 Apr, 04:32 pm | — | … | Cipla Limited has informed the Exchange about USFDA inspection at Company's manufacturing facility in Goa, India | nse |
| 16 Apr, 07:53 pm | — | … | Cipla Limited has informed the Exchange about Schedule of Earnings Conference call | nse |
| 31 Mar, 07:32 pm | — | … | Cipla Ltd - 500087 - Board Meeting Intimation for The Quarter And Year Ended 31St March, 2026 Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 30 Mar, 06:22 pm | — | … | Cipla Limited has informed the Exchange regarding Resignation of Mr. Umang Vohra as Managing Director & CEO of the company w.e.f. April 01, 2026. | nse |
| 30 Mar, 06:22 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Resignation of Director | bse |
| 30 Mar, 06:19 pm | — | … | Cipla Limited has informed the Exchange about change in Management | nse |
| 30 Mar, 06:18 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 26 Mar, 08:38 pm | — | … | Cipla Ltd - 500087 - General Updates | bse |
| 26 Mar, 08:38 pm | — | … | Mr Pradeep Bhadauria, Global Chief Scientific Officer has resigned to pursue interests outside Cipla and his last working day will be 31st March, 2026. | nse |
| 19 Mar, 05:39 pm | — | … | Cipla Ltd - 500087 - Corporate Action-Amalgamation/ Merger / Demerger | bse |
| 19 Mar, 05:35 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 19 Mar, 05:33 pm | — | … | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on March 19, 2026 regarding:1. Approved investment upto USD 100 million in the equity share capital of Cipla (EU) Limited, a whollyowned subsidiary of the Company for the purpose of providing onward financial assistance to InvaGen Pharmaceuticals Inc., wholly-owned subsidiary of Cipla (EU) Limited, to meet its capital expenditure, working capital requirements and other general corporate purposes.2. Approved Scheme of | nse |
| 19 Mar, 05:32 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 19 Mar, 05:28 pm | — | … | Cipla Limited has informed the Exchange regarding Outcome of Board Meeting held on March 19, 2026. | nse |
| 18 Mar, 07:29 pm | — | … | Cipla Limited has informed the Exchange regarding allotment of 1954 securities pursuant to ESOP/ESPS at its meeting held on March 18, 2026 | nse |
| 09 Mar, 10:52 pm | — | … | Cipla Ltd - 500087 - Update On US Food And Drug Administration (USFDA) Inspection On Pharmathen International S.A. | bse |
| 09 Mar, 10:50 pm | — | … | Cipla Limited has informed the Exchange about General Updates | nse |
| 02 Mar, 08:07 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 02 Mar, 08:06 pm | — | … | Cipla Limited has informed the Exchange about entering into a venture agreement with Kemwell Biopharma Private Limited ( Kemwell ) for incorporation of a joint venture company in India. | nse |
| 02 Mar, 07:30 pm | — | … | Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 02 Mar, 07:29 pm | — | … | Cipla Limited has informed the Exchange about incorporation of a wholly-owned step-down subsidiary named Cipla Middle East Company w.e.f. 1st March, 2026, in the Kingdom of Saudi Arabia. | nse |
| 26 Feb, 05:20 pm | — | … | Cipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |